According to the latest market research study released by Technavio, the global FISH probe market is expected to grow at a CAGR of more than 7% during the forecast period 2016-2020.
This market research report by Technavio provides an in-depth analysis of the market in terms of revenue and emerging market trends. The report also includes an up-to-date analysis and forecasts for various market segments and all geographical regions.
Click here to request a free sample of this report
Technavio research analysts categorize the global FISH probe market based on end-users:
Global FISH probe share by end-users 2015
|
Clinical procedures |
41.33% |
|
Research studies |
38.18% |
|
CD |
20.49% |
Source: Technavio
Global FISH probe market by clinical procedures
In 2015, the FISH proble market was dominated by the clinical procedures segment, which accounted for more than 41% of the total market share. Much of the segment’s high growth can be attributed to improvements in health infrastructure which has led to a rise in the number of diagnostic centers and health services. On the basis of service providers, the clinical procedures are categorized into hospital-based laboratories, stand-alone laboratories, and clinic-based laboratories. Hospital-based laboratories lead the clinical procedures segment owing to the high patient base and the subsequent presence of high test volumes in healthcare facilities. The stand-alone laboratories constitute the fastest-growing sub-segment due to increasing demand for POC tests (POCTs) and rising market penetration rates in emerging and underdeveloped regions such as APAC, South and Central America, and Africa.
“Clinical procedures are considered an integral part of the healthcare industry, as almost 80% of physician’s diagnoses depend on laboratory tests. With the growing preference for minimum contact time with physicians, clinical procedures are witnessing greater demand among end-users. Clinical laboratory services gather, interpret, and deliver precise information to physicians at the right time, thereby saving cost and time. They also offer a wide range of tests that aid in the detection of abnormalities and disease progression, including urine and blood tests to high-end genetic analysis such as molecular expression testing and FISH probe,” says Amber Chourasia, a senior analyst at Technavio for research on health and wellness.
Global FISH probe market by research studies
The research studies segment accounted for around 38% of the total market share in 2015 and is expected to grow at a CAGR of more than 7% over the forecast period. With the rapid growth of several developing countries such as India and China, more research facilities and institutes are expected to be established in these economies over the next four years. This will result in the use of more advanced technologies such as FISH probes for the diagnosis of diseases and discovery of drugs. Several countries across the globe are emphasizing on knowledge expansion and innovation and are making huge investments in R&D. The increase in the number of research and testing facilities, specifically in the field of pharmaceutical and biotechnology, will lead to a rise in demand for the FISH probe market for molecular diagnostics in the coming years.
Global FISH probe market by CD
The CD segment in the global FISH probe market is anticipated to grow at a CAGR of more than 58% by 2020. CD is used in personalized medicines and includes medical decisions, products and practices based on the patient’s genetic, genomic, and clinical information. In oncology, CD is based on FISH probes due to higher reliability, accuracy, sensitivity, consistency, and procedure reproducibility. This segment is primarily driven by advances in technologies such as NGS, owing to its capability of identifying multiple genes at a single time. At present, NGS-based CD tests are offered for cystic fibrosis. The CD manufacturers are engaged in developing tests for other life-threatening and chronic diseases. Several pharmaceutical firms are entering the global FISH probe market through strategic acquisitions and collaborations with NGS platform diagnostic firms.
CD in the oncology division is majorly molecular-based with various recent approvals for FISH probes, which offer the advantage of simultaneous evaluation of morphology and gene amplification.
The top leading vendors operating in the global FISH probe market are:
- Agilent Technologies
- Genemed
- Roche Diagnostics
- Thermo Fisher Scientific
Other prominent vendors in the market include Abnova Corporation, Abbott Molecular, BioDot, EXIQON, Bio-Rad Laboratories, Oxford Gene Technology, Perkin Elmer, and Sigma Aldrich.
A more detailed analysis is available in the Technavio report titled, ‘Global FISH Probe Market 2016-2020’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports:
- Global DNA Sequencing Products Market 2016-2020
- Global Fecal Occult Testing Market 2016-2020
- Global Transcriptomics Market 2016-2020
- Global Polymerase Chain Reaction Market 2016-2020
To read more press releases- click here
For any assistance or query, please contact our media team at:
media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com
